Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bateman

Showing results (231-240 of 345) with videos related to

Pageof 35
Sort By:
The New England Journal of Medicine|September 4, 2012
Tiotropium in asthma poorly controlled with standard combination therapyHuib A M Kerstjens, Michael Engel, Ronald Dahl, et al.
Trials|April 25, 2008
Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocolLara R Fairall, Max O Bachmann, Merrick F Zwarenstein, et al.
The Journal of Allergy and Clinical Immunology|March 11, 2016
Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trialEckard Hamelmann, Eric D Bateman, Christian Vogelberg, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 19, 2005
Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung diseaseS Den Boon, E D Bateman, D A Enarson, et al.
Royal Society Open Science|August 17, 2019
Mid-Devensian climate and landscape in England: new data from Finningley, South YorkshirePhilip I Buckland, Mark D Bateman, Ole Bennike, et al.
Respiratory Medicine|September 1, 2016
Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysisRonald Dahl, Michael Engel, Daniel Dusser, et al.
Respiratory Medicine|February 21, 2012
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trialEric D Bateman, Eugene R Bleecker, Jan Lötvall, et al.
Thorax|November 21, 2013
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF aloneEric D Bateman, Paul M O'Byrne, William W Busse, et al.
The European Respiratory Journal|February 25, 2022
Reply to: Cause or consequence?Eric D Bateman, David B Price, Hao-Chien Wang, et al.
The Lancet. Respiratory Medicine|March 5, 2015
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsMario Castro, James Zangrilli, Michael E Wechsler, et al.
Pageof 35

Showing results (231-240 of 345) with videos related to

Sort By:
Pageof 35
The New England Journal of Medicine|September 4, 2012
Tiotropium in asthma poorly controlled with standard combination therapyHuib A M Kerstjens, Michael Engel, Ronald Dahl, et al.
Trials|April 25, 2008
Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocolLara R Fairall, Max O Bachmann, Merrick F Zwarenstein, et al.
The Journal of Allergy and Clinical Immunology|March 11, 2016
Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trialEckard Hamelmann, Eric D Bateman, Christian Vogelberg, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 19, 2005
Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung diseaseS Den Boon, E D Bateman, D A Enarson, et al.
Royal Society Open Science|August 17, 2019
Mid-Devensian climate and landscape in England: new data from Finningley, South YorkshirePhilip I Buckland, Mark D Bateman, Ole Bennike, et al.
Respiratory Medicine|September 1, 2016
Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysisRonald Dahl, Michael Engel, Daniel Dusser, et al.
Respiratory Medicine|February 21, 2012
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trialEric D Bateman, Eugene R Bleecker, Jan Lötvall, et al.
Thorax|November 21, 2013
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF aloneEric D Bateman, Paul M O'Byrne, William W Busse, et al.
The European Respiratory Journal|February 25, 2022
Reply to: Cause or consequence?Eric D Bateman, David B Price, Hao-Chien Wang, et al.
The Lancet. Respiratory Medicine|March 5, 2015
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsMario Castro, James Zangrilli, Michael E Wechsler, et al.
Pageof 35